Colonic Mucosal Aberrant Crypt Foci: Are They Useful Intermediate Endpoints for Predicting and Understanding the Development of Colonic Mucosal Neoplasia?

Bjerknes M. and Cheng H. (1999). Colossal crypts bordering colon adenomas in APCMIN mice express full-length Apc. Am. J. Pathol. 154: 1831-1834.

Cameron IL , Garza J. , and Hardman WE (1996). Distribution of lymphoid nodules, aberrant crypt foci and tumours in the colon of carcinogen-treated rats. Br. J. Cancer 73: 893-898.

Chang WL , Chapkin RS , and Lupton JR (1997). Predictive value of proliferation, differentiation and apoptosis as intermediate markers for colon tumorigenesis. Carcinogenesis 18: 721-730.

Deschner EE (1974). Experimentally induced cancer of the colon. Cancer 34: 824-828.

Deschner EE and Maskens AP (1982). Significance of the labeling index and labeling distribution as kinetic parameters in colorectal mucosa of cancer patients and DMH treated animals. Cancer 50: 1136-1141.

Fearon ER and Vogelstein B. (1990). A genetic model of colorectal tumorigenesis. Cell 61: 759-767.

Food and Drug Administration ( 1997). Proposed Rule: Food Labeling: Health Claims; Soluble fiber from certain foods and coronary heart disease. Fed. Reg. 62: 28234.

Green SE , Chapman P. , Bum J. , Burt AD , Bennett M. , Appleton DR , Varma JS , and Mathers JC (1998). Colonic epithelial cell proliferation in hereditary non-polyposis colorectal cancer. Gut 43: 85-92.

Goodlad RA , Ratcliffe B. , Lee CY , and Wright NA (1995). Dietary fiber and the gastrointestinal tract: Differing trophic effects on muscle and mucosa of the stomach, small intestine and colon. Eur. J. Clin. Nutr. 49(suppl 3): S178-S181.

Isaacson P. and Atwood J. (1979). Failure to demonstrate specificity of the morphological and histochemical changes in the mucosa adjacent to colonic carcinoma (transitional mucosa). J. Clin. Pathol. 32: 214-218.

Jacoby RF , Marshell DJ , Moser AR , and Dove WF (1996). Chemoprevention spontaneous intestinal adenomas in the ApcMIN mouse model by the nonsteroidal anti-inflammatory drug piroxicam . Cancer Res. 56: 710-714.

Jass JR (1998). Diagnosis of hereditary non-polyposis colorectal cancer. Histopathology 32: 491-497.

Jass JR , Jioka Y. , Redojkovic MR , Allison LJ , and Lane MR (1997). Failure to detect colonic mucosal hyperproliferation in mutation positive members of a family with hereditary non-polyposis cancer . Histopathology 30: 201-207.

Kinzler KW and Vogelstein B. (1996). Lessons from hereditary colorectal cancer. Cell 87: 159-170.

Lipkin M. (1988). Biomarkers of increased susceptibility of gastrointestinal cancer: New application to studies of cancer prevention in human subjects . Cancer Res. 48: 235-245.

McShane LM , Kulldorff M. , Wargovich MJ , Woods C. , Purewal M. , Moler J. , and Schatzkin A. (1998). An evaluation of rectal mucosal proliferation measure variability sources in the Polyp Prevention Trial: Can we detect informative differences among individuals' proliferation measures amid the noise? Cancer Epidemiol. Biomark Prev. 7: 605-612.

Magnuson BA and Bird RP (1993). Reduction of aberrant crypt foci induced in rat colon with azoxymethane or methylnitrosourea by feeding cholic acid. Cancer Lett. 68: 15-23.

Moen Cja , Van der Valk MA , Bird RP , Hart Aam , and Demant P. (1996). Different genetic susceptibility to aberrant crypt and colon adenomas in mice. Cancer Res. 56: 2382-2386.

Oshima H. , Oshima M. , and Taketo MM (1997). Morphologic and molecular processes of polyp formation in Apc knockout mice. Cancer Res. 57: 1644-1649.

Steele VE , Moon RC , Lubet, RA , Boone CW , and Kelloff GJ (1994). Preclinical efficacy evaluation of potential chemopreventative agents in animal carcinogenesis models: Methods and results from the NCI chemoprevention drug development program. J. Cell Biochem. Suppl. 20: 32-54.

Takahashi S. , Ogawa K. , Ohshima H. , Esumi H. , Ito N. , and Sugimura T. (1991). Induction of aberrant crypt foci in the large intestine of F344 rats by oral administration of 2-amino-1-methyl-6-phenylimidazol-pyridine . Jpn. J. Cancer Res. 82: 135-137.

Wargovich MJ , Hams C. , Chen C. , Palmer C. , Steele VE , and Kelloff GJ (1992). Growth kinetics and chemoprevention of aberrant crypts in the rat colon. J. Cell Biochem. Suppl. 16C: 51-54.

Whiteley LO , Anver MR , Botts S. , and Jokinen MP (1996). Proliferative lesions of the intestine, salivary glands, oral cavity and esophagus in rats. In: Guides for Toxicologic Pathology. STP/ARP/ AFIP, Washington, D.C.

Whiteley LO , Higgins JM , Purdon MP , Ridder GM , and Bertram TA (1996). Evaluation in rats of the dose-response relationship among colonic mucosal growth, colonic fermentation, and dietary fiber. Dig. Dis. Sci. 41: 1458-1467.

Whiteley LO , Hudson L. , and Pretlow TP (1996). Aberrant crypt foci in the colonic mucosa of rats treated with a genotoxic and nongenotoxic colon carcinogen. Toxicol. Pathol. 24: 681-689.

Whiteley LO and Klurfeld DM (2000). Are dietary fiber-induced alterations in colonic epithelial cell proliferation predictive of fiber's effect on colon cancer? Nutr. Cancer (in press).

Whiteley LO , Purdon MP , Ridder GM , and Bertram TA (1996). The interactions of diet and colonic microflora in regulating colonic mucosal growth. Toxicol. Pathol. 24: 305-314.

Wilcox DK , Higgins J. , and Bertram TA (1992). Colonic epithelial cell proliferation in a rat model of nongenotoxin-induced colonic neoplasia. Lab. Invest. 67: 405-411.

Zheng Y. , Kramer PM , Lubet RA , Steele VE , Kelloff GJ , and Pereira MA (1999). Effect of retinoids on AOM-induced colon cancer in rats: Modulation of cell proliferation, apoptosis and aberrant crypt foci . Carcinogenesis 20: 255-260.